These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 19524585

  • 1. Moving beyond dichotomies in research on oral contraceptives: a comment on Edwards and O'Neal.
    Josephs RA.
    Horm Behav; 2009 Aug; 56(2):193-4. PubMed ID: 19524585
    [No Abstract] [Full Text] [Related]

  • 2. Oral contraceptives decrease saliva testosterone but do not affect the rise in testosterone associated with athletic competition.
    Edwards DA, O'Neal JL.
    Horm Behav; 2009 Aug; 56(2):195-8. PubMed ID: 19470364
    [Abstract] [Full Text] [Related]

  • 3. Women's intercollegiate volleyball and tennis: effects of warm-up, competition, and practice on saliva levels of cortisol and testosterone.
    Edwards DA, Kurlander LS.
    Horm Behav; 2010 Sep; 58(4):606-13. PubMed ID: 20615408
    [Abstract] [Full Text] [Related]

  • 4. Competition and testosterone.
    Edwards DA.
    Horm Behav; 2006 Dec; 50(5):681-3. PubMed ID: 17046761
    [No Abstract] [Full Text] [Related]

  • 5. Effects of ability- and chance-determined competition outcome on testosterone.
    van Anders SM, Watson NV.
    Physiol Behav; 2007 Mar 16; 90(4):634-42. PubMed ID: 17223140
    [Abstract] [Full Text] [Related]

  • 6. Testosterone change after losing predicts the decision to compete again.
    Mehta PH, Josephs RA.
    Horm Behav; 2006 Dec 16; 50(5):684-92. PubMed ID: 16928375
    [Abstract] [Full Text] [Related]

  • 7. Testosterone responsiveness to winning and losing experiences in female soccer players.
    Oliveira T, Gouveia MJ, Oliveira RF.
    Psychoneuroendocrinology; 2009 Aug 16; 34(7):1056-64. PubMed ID: 19278791
    [Abstract] [Full Text] [Related]

  • 8. Exogenous testosterone in women enhances and inhibits competitive decision-making depending on victory-defeat experience and trait dominance.
    Mehta PH, van Son V, Welker KM, Prasad S, Sanfey AG, Smidts A, Roelofs K.
    Psychoneuroendocrinology; 2015 Oct 16; 60():224-36. PubMed ID: 26209809
    [Abstract] [Full Text] [Related]

  • 9. Patterns of testosterone responsiveness and immunity in relation to competitive behavior in chicks.
    Ros AF.
    Horm Behav; 2008 Aug 16; 54(2):234-7. PubMed ID: 18417128
    [No Abstract] [Full Text] [Related]

  • 10. Competitors who choose to be red have higher testosterone levels.
    Farrelly D, Slater R, Elliott HR, Walden HR, Wetherell MA.
    Psychol Sci; 2013 Oct 16; 24(10):2122-4. PubMed ID: 23917700
    [No Abstract] [Full Text] [Related]

  • 11. No place like home: testosterone responses to victory depend on game location.
    Carré JM.
    Am J Hum Biol; 2009 Oct 16; 21(3):392-4. PubMed ID: 19127526
    [Abstract] [Full Text] [Related]

  • 12. Testosterone binding affinity (TBA): alterations produced by pathological and physiological states.
    Pohlman C, Hallberg MC, Zorn EM, Guevara A, Wieland RG.
    Am J Med Sci; 1969 Oct 16; 258(4):270-4. PubMed ID: 5823463
    [No Abstract] [Full Text] [Related]

  • 13. When are low testosterone levels advantageous? The moderating role of individual versus intergroup competition.
    Mehta PH, Wuehrmann EV, Josephs RA.
    Horm Behav; 2009 Jun 16; 56(1):158-62. PubMed ID: 19362091
    [Abstract] [Full Text] [Related]

  • 14. Discussion: 'Factors influencing oral contraceptive effectiveness' by Dinger et al.
    Madden T, Allsworth JE, Tepe M, Goetzinger K, Czarnecki D, Grentzer J.
    Am J Obstet Gynecol; 2009 Sep 16; 201(3):e1-4. PubMed ID: 19733271
    [No Abstract] [Full Text] [Related]

  • 15. [Doping in the horse: an FEI perspective].
    Sluyter F.
    Tijdschr Diergeneeskd; 2004 Dec 01; 129(23):813. PubMed ID: 15624882
    [No Abstract] [Full Text] [Related]

  • 16. [Toxicity studies as an aid in judging secondary effects in man].
    Westerholm B.
    Lakartidningen; 1974 Jun 26; 71(26):2604-5. PubMed ID: 4209806
    [No Abstract] [Full Text] [Related]

  • 17. Clinical experiences with ciclofarlutal.
    Hren M.
    Panminerva Med; 1966 Apr 26; 8(4):130-3. PubMed ID: 5944137
    [No Abstract] [Full Text] [Related]

  • 18. [Oral contraceptives in dermatology].
    Sancho B, Guerra-Tapia A.
    Actas Dermosifiliogr; 2009 Apr 26; 100(6):445-55. PubMed ID: 19709548
    [Abstract] [Full Text] [Related]

  • 19. Clinical aspects of oral gestogens.
    WHO Chron; 1966 Jun 26; 20(6):210-2. PubMed ID: 5940178
    [No Abstract] [Full Text] [Related]

  • 20. Matrix effects on an antigen immobilized format for competitive enzyme immunoassay of salivary testosterone.
    Mitchell JS, Lowe TE.
    J Immunol Methods; 2009 Sep 30; 349(1-2):61-6. PubMed ID: 19660465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.